Design and Synthesis of Peptidomimetic Factor VIIa Inhibitors

被引：2

作者：

Shiraishi, Takuya ^{[1
]}

Kadono, Shojiro ^{[1
]}

Haramura, Masayuki ^{[1
]}

Kodama, Hirofumi ^{[1
]}

Ono, Yoshiyuki ^{[1
]}

Iikura, Hitoshi ^{[1
]}

Esaki, Tohru ^{[1
]}

Koga, Takaki ^{[1
]}

Hattori, Kunihiro ^{[1
]}

Watanabe, Yoshiaki ^{[1
]}

Sakamoto, Akihisa ^{[1
]}

Yoshihashi, Kazutaka ^{[1
]}

Kitazawa, Takehisa ^{[1
]}

Esaki, Keiko ^{[1
]}

Ohta, Masateru ^{[1
]}

Sato, Haruhiko ^{[1
]}

Kozono, Toshiro ^{[1
]}

机构：

[1] Chugai Pharmaceut Co Ltd, Fuji Gotemba Res Labs, Shizuoka 4128513, Japan

来源：

CHEMICAL & PHARMACEUTICAL BULLETIN | 2010年 / 58卷 / 01期

关键词：

factor VIIa; X-ray; 2Xactivated partial thromboplastin time/2Xprothrombin time; thromboembolic disorder; peptidomimetic inhibitor; FACTOR-VIIA/TISSUE-FACTOR; COAGULATION-FACTOR VIIA; TISSUE FACTOR MUTANT; CRYSTAL-STRUCTURE; P3; MOIETIES; FACTOR XA; COMPLEX; THROMBOSIS; OPTIMIZATION; EFFICACY;

D O I：

10.1248/cpb.58.38

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Selective factor Vila-tissue factor complex (FVIIa/TF) inhibition is regarded as a promising target for developing new anticoagulant drugs. In previous reports, we described a S3 subsite found in the X-ray crystal structure of compound 2 that bound to FVIIa/soluble tissue factor (sTF). Based on the X-ray crystal structure information and with the aim of improving the inhibition activity for FVIIa/TF and selectivity against other serine proteases, we synthesized derivatives by introducing substituents at position 5 of the indole ring of compound 2. Among them, compound 16 showed high selectivity against other serine proteases. Contrary to our expectations, compound 16 did not occupy the S3-subsite; X-ray structure analysis revealed that compound 16 improved selectivity by forming hydrogen bonds with Gln217, Thr99 and Asn100.

引用

页码：38 / 44

页数：7

共 50 条

[1] Design, synthesis and SAR of novel, heterocyclic Factor VIIa inhibitors
Rai, Roopa
Kolesnikov, Aleksandr
Sprengeler, Paul A.
Torkelson, Steven
Ton, Tony
Hendrix, John
Stephens, Robin
Shrader, William D.
Katz, Bradley A.
Yu, Christine
Cabuslay, Ronnel
Sanford, Ellen
Janc, Jim
Gjerstad, Erik
Young, Wendy B.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
[2] Design and synthesis of orally bioavailable TF-Factor VIIa inhibitors
Glunz, Peter W.
Zhang, Xiaojun
Zou, Yan
Jiang, Wen
Jacutin-Porte, Swanee
Nirschl, Alexandra H.
Cheng, Xuhong
Weigelt, Carolyn A.
Cheney, Daniel L.
Wei, Anzhi
Rendina, Alan R.
Luettgen, Joseph M.
Knabb, Robert M.
Luo, Gang
Harper, Timothy
Wong, Pancras C.
Wexler, Ruth R.
Priestley, E. Scott
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
[3] Design and synthesis of conformationally rigid macrocyclic tissue factor-factor VIIa inhibitors
Glunz, Peter W.
Zhang, Xiaojun
Wurtz, Nicholas
Zou, Yan
Delucca, Inda
Parkhurst, Brandon
Cheney, Daniel
Mueller, Luciano
Wei, Anzhi
Luettgen, Joseph M.
Knabb, Robert M.
Harper, Timothy
Wong, Pancras C.
Wexler, Ruth R.
Priestley, E. Scott
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
[4] Design, synthesis, and in vitro activity of peptidomimetic inhibitors of myeloid differentiation factor 88
Fanto, Nicola
Gallo, Grazia
Ciacci, Andrea
Semproni, Mauro
Vignola, Davide
Quaglia, Marco
Bombardi, Valentina
Mastroianni, Domenico
Zibella, M. Pia
Basile, Giancarlo
Sassano, Marica
Ruggiero, Vito
De Santis, Rita
Carminatit, Paolo
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (05) : 1189 - 1202
[5] Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants
Lin, Jian
Deng, Hongfeng
Jin, Lei
Pandey, Pramod
Quinn, Jesse
Cantin, Susan
Rynkiewicz, Michael J.
Gorga, Joan C.
Bibbins, Frank
Celatka, Cassandra A.
Nagafuji, Pamela
Bannister, Thomas D.
Meyers, Harold V.
Babine, Robert E.
Hayward, Neil J.
Weaver, David
Benjamin, Howard
Stassen, Frans
Abdel-Meguid, Sherin S.
Strickler, James E.
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (26) : 7781 - 7791
[6] DESIGN AND SYNTHESIS OF NONPEPTIDE PEPTIDOMIMETIC INHIBITORS OF RENIN
SMITH, AB
AKAISHI, R
JONES, DR
KEENAN, TP
GUZMAN, MC
HOLCOMB, RC
SPRENGELER, PA
WOOD, JL
HIRSCHMANN, R
HOLLOWAY, MK
BIOPOLYMERS, 1995, 37 (01) : 29 - 53
[7] Design, synthesis and biological evaluation of peptidomimetic FXIa inhibitors
Lin, J
Deng, HF
Jin, L
Pandey, P
Rynkiewicz, M
Bibbins, F
Cantin, S
Quinn, J
Magee, S
Gorga, J
Celatka, C
Nagafuji, P
Bannister, T
Meyers, HV
Babine, R
Hayward, N
Abdel-Meguid, SS
Strickler, J
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U153 - U153
[8] Design, synthesis and biological evaluation of peptidomimetic inhibitors of thrombin
Ogbu, CO
Boatman, PD
Eguchi, M
Cao, GL
Nakanishi, H
Kahn, M
Tulinsky, A
Padmanabhan, K
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 60 - MEDI
[9] Design of selective phenylglycine amide tissue factor/factor VIIa inhibitors
Zbinden, KG
Banner, DW
Ackermann, J
D'Arcy, A
Kirchhofer, D
Ji, YH
Tschopp, TB
Wallbaum, S
Weber, L
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (03) : 817 - 822
[10] Design, synthesis, and crystal structure of selective 2-pyridone tissue factor VIIa inhibitors
Parlow, JJ
Kurumbail, RG
Stegeman, RA
Stevens, AM
Stallings, WC
South, MS
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (22) : 4696 - 4701

← 1 2 3 4 5 →